Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2016 Sep 19;6:32971. doi: 10.1038/srep32971

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2016, The Author(s)

This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

PMC Copyright notice

(A) The percentage of surviving liver allografts with different dosages of donor imDex. (B) ImDex derived from donors (BN), recipients (Lewis), or other allogeneic donors (F344) were injected at 20 μg into recipient rats. (C) Recipients were treated with different Tregs. (D) The liver allograft survival with the administration of 20 μg imDex and/or BN-specific/fresh Tregs. ^aCompared with untreated group; ^bcompared with 20 μg BN derived imDex treatment group; ^ccompared with BN-specific Tregs treatment group; ^dcompared with 20 μg imDex plus BN specific Tregs treatment group. One a/b/c/d, p < 0.05; two a/b/c/d, p < 0.01; three a/b/c/d, p < 0.001; four a/b/c/d, p < 0.0001.